"Patients with cancer are treated with drugs already approved by the U.S. Food and Drug Administration (FDA) or with an investigational agent in a clinical trial. But there are some patients who may need access to investigational drugs outside the realm of a clinical trial..."

Read more about how Project Faciliate and the Foundation are working together to simplify the expanded access process: http://obroncology.com/article/fda-eases-access-to-unapproved-cancer-drugs/